Cargando…

Next-generation sequencing of the human TRPV1 gene and the regulating co-players LTB4R and LTB4R2 based on a custom AmpliSeq(™) panel

BACKGROUND: Transient receptor potential cation channel subfamily V member 1 (TRPV1) are sensitive to heat, capsaicin, pungent chemicals and other noxious stimuli. They play important roles in the pain pathway where in concert with proinflammatory factors such as leukotrienes they mediate sensitizat...

Descripción completa

Detalles Bibliográficos
Autores principales: Kringel, Dario, Sisignano, Marco, Zinn, Sebastian, Lötsch, Jörn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5489211/
https://www.ncbi.nlm.nih.gov/pubmed/28658281
http://dx.doi.org/10.1371/journal.pone.0180116
_version_ 1783246767587852288
author Kringel, Dario
Sisignano, Marco
Zinn, Sebastian
Lötsch, Jörn
author_facet Kringel, Dario
Sisignano, Marco
Zinn, Sebastian
Lötsch, Jörn
author_sort Kringel, Dario
collection PubMed
description BACKGROUND: Transient receptor potential cation channel subfamily V member 1 (TRPV1) are sensitive to heat, capsaicin, pungent chemicals and other noxious stimuli. They play important roles in the pain pathway where in concert with proinflammatory factors such as leukotrienes they mediate sensitization and hyperalgesia. TRPV1 is the target of several novel analgesics drugs under development and therefore, TRPV1 genetic variants might represent promising candidates for pharmacogenetic modulators of drug effects. METHODS: A next-generation sequencing (NGS) panel was created for the human TRPV1 gene and in addition, for the leukotriene receptors BLT1 and BLT2 recently described to modulate TRPV1 mediated sensitisation processes rendering the coding genes LTB4R and LTB4R2 important co-players in pharmacogenetic approaches involving TRPV1. The NGS workflow was based on a custom AmpliSeq(™) panel and designed for sequencing of human genes on an Ion PGM(™) Sequencer. A cohort of 80 healthy subjects of Western European descent was screened to evaluate and validate the detection of exomic sequences of the coding genes with 25 base pair exon padding. RESULTS: The amplicons covered approximately 97% of the target sequence. A median of 2.81 x 10(6) reads per run was obtained. This identified approximately 140 chromosome loci where nucleotides deviated from the reference sequence GRCh37 hg19 comprising the three genes TRPV1, LTB4R and LTB4R2. Correspondence between NGS and Sanger derived nucleotide sequences was 100%. CONCLUSIONS: Results suggested that the NGS approach based on AmpliSeq(™) libraries and Ion Personal Genome Machine (PGM) sequencing is a highly efficient mutation detection method. It is suitable for large-scale sequencing of TRPV1 and functionally related genes. The method adds a large amount of genetic information as a basis for complete analysis of TRPV1 ion channel genetics and its functional consequences.
format Online
Article
Text
id pubmed-5489211
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-54892112017-07-11 Next-generation sequencing of the human TRPV1 gene and the regulating co-players LTB4R and LTB4R2 based on a custom AmpliSeq(™) panel Kringel, Dario Sisignano, Marco Zinn, Sebastian Lötsch, Jörn PLoS One Research Article BACKGROUND: Transient receptor potential cation channel subfamily V member 1 (TRPV1) are sensitive to heat, capsaicin, pungent chemicals and other noxious stimuli. They play important roles in the pain pathway where in concert with proinflammatory factors such as leukotrienes they mediate sensitization and hyperalgesia. TRPV1 is the target of several novel analgesics drugs under development and therefore, TRPV1 genetic variants might represent promising candidates for pharmacogenetic modulators of drug effects. METHODS: A next-generation sequencing (NGS) panel was created for the human TRPV1 gene and in addition, for the leukotriene receptors BLT1 and BLT2 recently described to modulate TRPV1 mediated sensitisation processes rendering the coding genes LTB4R and LTB4R2 important co-players in pharmacogenetic approaches involving TRPV1. The NGS workflow was based on a custom AmpliSeq(™) panel and designed for sequencing of human genes on an Ion PGM(™) Sequencer. A cohort of 80 healthy subjects of Western European descent was screened to evaluate and validate the detection of exomic sequences of the coding genes with 25 base pair exon padding. RESULTS: The amplicons covered approximately 97% of the target sequence. A median of 2.81 x 10(6) reads per run was obtained. This identified approximately 140 chromosome loci where nucleotides deviated from the reference sequence GRCh37 hg19 comprising the three genes TRPV1, LTB4R and LTB4R2. Correspondence between NGS and Sanger derived nucleotide sequences was 100%. CONCLUSIONS: Results suggested that the NGS approach based on AmpliSeq(™) libraries and Ion Personal Genome Machine (PGM) sequencing is a highly efficient mutation detection method. It is suitable for large-scale sequencing of TRPV1 and functionally related genes. The method adds a large amount of genetic information as a basis for complete analysis of TRPV1 ion channel genetics and its functional consequences. Public Library of Science 2017-06-28 /pmc/articles/PMC5489211/ /pubmed/28658281 http://dx.doi.org/10.1371/journal.pone.0180116 Text en © 2017 Kringel et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Kringel, Dario
Sisignano, Marco
Zinn, Sebastian
Lötsch, Jörn
Next-generation sequencing of the human TRPV1 gene and the regulating co-players LTB4R and LTB4R2 based on a custom AmpliSeq(™) panel
title Next-generation sequencing of the human TRPV1 gene and the regulating co-players LTB4R and LTB4R2 based on a custom AmpliSeq(™) panel
title_full Next-generation sequencing of the human TRPV1 gene and the regulating co-players LTB4R and LTB4R2 based on a custom AmpliSeq(™) panel
title_fullStr Next-generation sequencing of the human TRPV1 gene and the regulating co-players LTB4R and LTB4R2 based on a custom AmpliSeq(™) panel
title_full_unstemmed Next-generation sequencing of the human TRPV1 gene and the regulating co-players LTB4R and LTB4R2 based on a custom AmpliSeq(™) panel
title_short Next-generation sequencing of the human TRPV1 gene and the regulating co-players LTB4R and LTB4R2 based on a custom AmpliSeq(™) panel
title_sort next-generation sequencing of the human trpv1 gene and the regulating co-players ltb4r and ltb4r2 based on a custom ampliseq(™) panel
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5489211/
https://www.ncbi.nlm.nih.gov/pubmed/28658281
http://dx.doi.org/10.1371/journal.pone.0180116
work_keys_str_mv AT kringeldario nextgenerationsequencingofthehumantrpv1geneandtheregulatingcoplayersltb4randltb4r2basedonacustomampliseqpanel
AT sisignanomarco nextgenerationsequencingofthehumantrpv1geneandtheregulatingcoplayersltb4randltb4r2basedonacustomampliseqpanel
AT zinnsebastian nextgenerationsequencingofthehumantrpv1geneandtheregulatingcoplayersltb4randltb4r2basedonacustomampliseqpanel
AT lotschjorn nextgenerationsequencingofthehumantrpv1geneandtheregulatingcoplayersltb4randltb4r2basedonacustomampliseqpanel